March Biosciences Funding: $52M Raised, Series A (2024)
March Biosciences is based in Houston. It has raised $52M in total funding. Latest round: Series A.
March Biosciences funding overview
March Biosciences is based in Houston. March Biosciences has raised $52M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in October 2024. The round record for March Biosciences runs through 2024; nothing later has been disclosed. Investors on record include Cancer Prevention and Research Institute of Texas (CPRIT).
March Biosciences at a glance
Total raised
$52M
Latest round
Series A
Latest round date
October 2024
Headquarters
Houston
Notable investors
Cancer Prevention and Research Institute of Texas (CPRIT)
Frequently asked about March Biosciences funding
How much has March Biosciences raised?
March Biosciences has raised $52M in total disclosed funding across the rounds on record.
Who has invested in March Biosciences?
Cancer Prevention and Research Institute of Texas (CPRIT) are named among the investors backing March Biosciences.
What was the latest March Biosciences funding round?
The most recent disclosed round is a Series A, announced in October 2024.
Where is March Biosciences based?
March Biosciences is based in Houston.
When did March Biosciences last raise?
The last disclosed March Biosciences round closed in October 2024 at Series A.
We update the March Biosciences record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Houston and their backers are listed below.
